Form D · Other Health Care
INVO Bioscience, Inc.
Sarasota, FL · CIK 0001417926
Offering snapshot reported Apr 6, 2023 · SEC filing
- Reported sold
- $2.98M Offering amount: $2.98M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 23, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2023 | Initial | $2,976,200 | No comparison | 1 | SEC filing |
| Mar 6, 2023 | Amendment | $500,000 | $200,000vs Feb 17, 2023 | 2 | SEC filing |
| Feb 17, 2023 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jan 11, 2023 | Initial | $275,000 | No comparison | 7 | SEC filing |
| Jul 15, 2020 | Amendment | $3,494,840 | $1,389,840vs May 28, 2020 | 22 | SEC filing |
| May 28, 2020 | Initial | $2,105,000 | No comparison | 8 | SEC filing |
| Jan 24, 2018 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Oct 14, 2009 | Initial | $545,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $149K
- Finders' fees
- $0
- Form D file number
- 021-478067
The combined effective offering price of each warrant which was combined with a registered share of common stock or a pre-funded warrant in lieu was $0.815, or aggregate gross proceeds of approximately $3 million.
Maxim Group LLC ("Maxim"), acted as the placement agent in connection with the offering. Maxim received an aggregate fee equal to 5.0% of the gross proceeds raised in the offering. Maxim also received a warrant to purchase 147,200 shares of common stock
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| MAXIM GROUP LLC | 120708 |
Source: Form D, filed Apr 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert J Bowdring | Director |
| Michael Campbell | Executive |
| Trent Davis | Director |
| Kevin Doody | Director |
| Andrea Goren | Executive |
| Debra Hoopes | Executive |
| Kathleen T. Karloff | Director |
| Rebecca Messina | Director |
| Claude Ranoux | Executive |
| Barbara Ryan | Director |
| Jeffrey Segal | Director |
| Steven Shum | Director, Executive |
| Matthew Szot | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
5582 Broadcast Court
Sarasota, FL, 34240
Sarasota, FL, 34240